Beauty Health Company (The) - Ordinary Shares - Class A Forecast, price target & analysts
Beauty Health Company (The) - Ordinary Shares - Class A Target price 2026 - Analyst rating & recommendation
Beauty Health Company (The) - Ordinary Shares - Class A Classifications & Recommendation
Beauty Health Company (The) - Ordinary Shares - Class A Price Target
| Target Price | $0.97 |
| Price | $0.66 |
| Potential |
45.76%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Beauty Health Company (The) - Ordinary Shares - Class A 2027 .
The average Beauty Health Company (The) - Ordinary Shares - Class A target price is $0.97.
This is
45.76%
register free of charge
$1.58
136.91%
register free of charge
$0.71
6.35%
register free of charge
|
|
| A rating was issued by 14 analysts: 1 Analysts recommend Beauty Health Company (The) - Ordinary Shares - Class A to buy, 8 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Beauty Health Company (The) - Ordinary Shares - Class A stock has an average upside potential 2027 of
45.76%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 300.79 | 290.72 |
| 10.02% | 3.35% | |
| EBITDA Margin | 2.40% | 15.20% |
| 178.01% | 532.37% | |
| Net Margin | -3.16% | -7.50% |
| 63.64% | 136.97% |
11 Analysts have issued a sales forecast Beauty Health Company (The) - Ordinary Shares - Class A 2026 . The average Beauty Health Company (The) - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Beauty Health Company (The) - Ordinary Shares - Class A EBITDA forecast 2026. The average Beauty Health Company (The) - Ordinary Shares - Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Beauty Health Company (The) - Ordinary Shares - Class A Analysts have issued a net profit forecast 2026. The average Beauty Health Company (The) - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.08 | -0.17 |
| 66.67% | 112.50% | |
| P/E | negative | |
| EV/Sales | 0.78 |
11 Analysts have issued a Beauty Health Company (The) - Ordinary Shares - Class A forecast for earnings per share. The average Beauty Health Company (The) - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Beauty Health Company (The) - Ordinary Shares - Class A...
Current Beauty Health Company (The) - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Roth Capital |
Locked
➜
Locked
|
Locked | May 20 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 01 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Mar 16 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 13 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jan 21 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Roth Capital:
Locked
➜
Locked
|
May 20 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 01 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Mar 16 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 13 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jan 21 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 22 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
